|
|
Volumn 49, Issue 4, 2009, Pages 477-482
|
|
Assessment of the effects of renal impairment on the pharmacokinetic profile of fesoterodine
a
|
|
Author keywords
Antimuscarinic; Fesoterodine; Overactive bladder; Renal impairment
|
|
Indexed keywords
5 HYDROXYMETHYL TOLTERODINE;
CREATININE;
DRUG METABOLITE;
FESOTERODINE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG URINE LEVEL;
FEMALE;
HEART PALPITATION;
HUMAN;
KIDNEY CLEARANCE;
KIDNEY DISEASE;
MALE;
SINGLE DRUG DOSE;
URINARY TRACT INFECTION;
ADMINISTRATION, ORAL;
BENZHYDRYL COMPOUNDS;
CREATININE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MUSCARINIC ANTAGONISTS;
RENAL INSUFFICIENCY;
TIME FACTORS;
|
|
EID: 63849202904
PISSN: 00912700
EISSN: 15524604
Source Type: Journal
DOI: 10.1177/0091270009332434 Document Type: Article |
|
Times cited : (18)
|
|
References (8)
|
